september 27, 2007 health information exchange: linking practitioners and public health for decision...
TRANSCRIPT
September 27, 2007
Health Information Exchange:Linking Practitioners and Public
Health for Decision SupportStephen M. DownsIndiana University
Children’s Health Services ResearchRegenstrief Institute
September 27, 2007
Overview
• The Indiana Network for Patient Care (INPC) and the Indiana Health Information Exchange (IHIE)
• Real-time Decision Support for Practitioners – Adaptive Turnaround Documents
• Practitioner Data for Public Health – Disease Surveillance
September 27, 2007
Concept
• HIE connects health systems & providers• Creates opportunities for decision support• Patterns of care identify opportunities for
decision support & quality improvement– Patients with diabetes need annual urinary
microalbumin testing– Infants with positive newborn screens must be located
and treated immediately– Health departments need to respond to disease
outbreaks
September 27, 2007
What’s Needed
• A mechanism for 2-way communications with physicians in the INPC
• We have used Adaptive Turnaround Document Technology (ATD) for decision support in our clinics
• Adapting to the INPC
September 27, 2007
What is an Adaptive Turnaround Document (ATD)?
• Computer Generated
• Paper
• Delivers tailored information
• Scannable
• Captures structured data– Computer, scanner, or fax
September 27, 2007
Applying ATD Technology on a Regional Basis
• Indiana Network for Patient Care (INPC)
• 21 hospitals
• County and State Health Departments
• RxHub
• Medicaid administrative data
• Over one billion coded results
September 27, 2007
September 27, 2007
How it was accomplished (technical)
• Federated repository
• Data from difference sources are stored in separate physical files
• Global patient index
• Same data structure and data dictionary
• Data arrive by HL7 (also DICOM, NCPDP)– Parsed– Translated
September 27, 2007
Docs4Docs - Links to clinical providers
• Results delivery service
• All hospitals send reports through same mechanism (HL7)
• HL7 results messages flow through INPC and are routed to MD in-boxes or faxes
• Eliminates mail costs
September 27, 2007
INPCINPC
HL7 QUEUE
Repository
DSS
HL7
Docs4Docs ©
September 27, 2007
Improving Diabetes Management
• ADA Guidelines– Microalbumin measured annually
• Monitor HL7 messages for Hgb A1C– Proxy for diabetes
• Check INPC for microalbumin in the last 12 months– If none, alert physician
September 27, 2007
Methodist Hospital Enhanced Report Name: Mkhemtest, mhtest Department of Pathology MRN: 007222030 And Laboratory Medicine DOB: 09/10/67 Sex: Female 1701 North Senate Blvd Home: (457) 348-9794 Indianapolis, IN 46206 Copy for: Rougraf, Bruce Date: Mon 02/23/2004 01:23 PM Accession: #04-054-000014 Account: 010001000234 Ordered by: Rougraf, Bruce T Location: HRTF
** Glycosolated Hemaglobin **
Procedure Units Ref Range Hgb A1C 8.5 H percent [<7] All tests performed at Clarian/Methodist Lab, 1701 N Senate Blvd, Indpls, IN 46202 Goal 15 Jun
2005 22 Aug 2005
2 Mach 2006
29 Oct 2006
Due
Physician visit every 6 months or less
X [_}Done [_}Scheduled [_|_]/[_|_]/[_|_] (Date)
HgbA1C every 6 months 8.5 Microalbumin annually [_}Done
[_}Scheduled [_|_]/[_|_]/[_|_] (Date)
Creatinine clearance & serum protein yearly if positive microalbumin
[_}Done [_}Scheduled [_|_]/[_|_]/[_|_] (Date)
Lipid profile annually X Ophtalmologic exam annually [_}Done
[_}Scheduled [_|_]/[_|_]/[_|_] (Date)
Dental visit every 6 months X [_}Done [_}Scheduled [_|_]/[_|_]/[_|_] (Date)
Influenza vaccine annually X Pneumococcal vaccine once X
[_] This is not my patient. The additional clinical context above was useful in caring for this patient. Stongly Somewhat Neutral Somewhat Strongly Agree Agree Disagree Disagree
Clinical data provided should always be considered incomplete and you should
exercise appropriate clinical judgment.
Procedure Units Ref Range Hgb A1C 8.5 H percent [<7]
Goal 15 Jun 2005
22 Aug 2005
2 Mach 2006
29 Oct 2006
Due
Physician visit every 6 months or less
X [_}Done [_}Scheduled [_|_]/[_|_]/[_|_] (Date)
HgbA1C every 6 months 8.5 Microalbumin annually [_}Done
[_}Scheduled [_|_]/[_|_]/[_|_] (Date)
Creatinine clearance & serum protein yearly if positive microalbumin
[_}Done [_}Scheduled [_|_]/[_|_]/[_|_] (Date)
Lipid profile annually X Ophtalmologic exam annually [_}Done
[_}Scheduled [_|_]/[_|_]/[_|_] (Date)
Dental visit every 6 months X [_}Done [_}Scheduled [_|_]/[_|_]/[_|_] (Date)
Influenza vaccine annually X Pneumococcal vaccine once X
[_] This is not my patient.
September 27, 2007
Simulating the RuleMicroalbumins & A1Cs in 2005
Hosp Pats Albumin % Albumin %
1 8430 2898 34% 2931 35%
2 4055 168 4% 181 4%
3 7673 1270 17% 1345 18%
4 10927 2647 24% 2683 25%
5 16239 5113 31% 5213 32%
TOTAL 47324 A1Cs 73482 201 alerts per day
September 27, 2007
A Test by Any Other Name…
• Hemaglobin A1C– Glycated Hgb– Glycated Hb– Glycos Hgb A-1– Hgb Clycosylated– HGBA1C:EIA– HGBA1C:HPLC– HgbA1C % Ser EIA– Hgb A1c Bld Qn
• Microalbumin– Microalbomin 24h Ur– Microalbumin R-Ur Qn– Microalbomin Timed
Urine– Microalbumin 24h Ur
Cnc– Microalbomin Ur Qn
mg/dl– Albumin Ur Qn Elp
September 27, 2007
Another Example:Newborn Screening
• Virtually all newborns in the US
• Blood spot obtained by heelstick
• Tested for inborn errors of metabolism and other conditions
• Early treatment may be life saving
September 27, 2007
Expanded Newborn Screening
• Tandem Mass Spectrometry
• Over 50 Conditions
• Prevent Morbidity and Mortality
• Save Costs
September 27, 2007
Challenges
• Most Conditions Rare– MDs Unfamiliar
• Families Need Guidance
• Diagnosis & Treatment Must Be Timely– Who has the baby?
• No Mechanisms for LTFU
September 27, 2007
Solution
• Regional health information network
• Two way communication with providers
September 27, 2007
Project Objectives
• Adaptive turnaround document technology to facilitate communication: NBS program, subspecialists, medical home– Provide “just in time” information to the
primary care clinician & family– Reduce the risk of “missed opportunities” to
screen– Facilitate tracking of children with detected
conditions
September 27, 2007
HL7
INPC
ISDH
ATDATD
September 27, 2007
Three Ways ATDs Can Enhance the NBS Program
• Just-in-time information to the medical home (physicians and families)
• Prevent missed opportunities to screen
• Long term tracking of children with identified conditions
September 27, 2007
Jennifer D. Patient DOB: 14 May 2007 Newborn Screening Alert: Elevated C8 with Lesser Elevations of C6 and C10 Acylcarnitine Suggestive of Medium-chain Acyl-CoA Dehydrogenase (MCAD) Deficiency Condition Description: MCAD deficiency is a fatty acid oxidation (FAO) disorder. FAO occurs during prolonged fasting and/or periods of increased energy demands (fever, stress) when energy production relies increasingly on fat metabolism. In an FAO disorder, fatty acids and potentially toxic derivatives accumulate because of a deficiency in one of the mitochondrial FAO enzymes. MEDICAL EMERGENCY - TAKE THE FOLLOWING IMMEDIATE ACTIONS: Contact family to inform them of the newborn screening result and ascertain clinical status
(poor feeding, vomiting, lethargy). Consult with pediatric metabolic specialist. Evaluate the newborn (poor feeding, lethargy, hypotonia, hepatomegaly). If signs are present
or infant is ill, initiate emergency treatment with IV glucose. Transport to hospital for further treatment in consultation with metabolic specialist. If infant is normal initiate timely confirmatory/diagnostic testing, as recommended by specialist.
Educate family about need for infant to avoid fasting. Even if mildly ill, immediate treatment with IV glucose is needed.
Report findings to newborn screening program. Diagnostic Evaluation: Plasma acylcarnitine analysis will show elevated octanoylcarnitine (C8). Urine acylglycine will show elevated hexanoylglycine. Diagnosis is confirmed by mutation analysis of the MCAD gene. Please check ALL of the following that apply: [ ] Family contacted [ ] Newborn clinical status assessed
[ ] Problems (poor feeding, vomiting, lethargy, hypotonia, hepatomegaly) [ ] Treated with IV glucose [ ] Infant stable
[ ] Family provided attached educational materials Diagnostic Evaluation [ ] Plasma acylcarnitine sent [ ] Referral made to metabolic center [ ] Family could not be contacted [ ] This is not my patient
Just-in-Time Information for the Primary Care Physician
September 27, 2007
Jennifer D. Patient DOB: 14 May 2007 Newborn Screening Alert: Elevated C8 with Lesser Elevations of C6 and C10 Acylcarnitine Suggestive of Medium-chain Acyl-CoA Dehydrogenase (MCAD) Deficiency Condition Description: MCAD deficiency is a fatty acid oxidation (FAO) disorder. FAO occurs during prolonged fasting and/or periods of increased energy demands (fever, stress) when energy production relies increasingly on fat metabolism. In an FAO disorder, fatty acids and potentially toxic derivatives accumulate because of a deficiency in one of the mitochondrial FAO enzymes. MEDICAL EMERGENCY - TAKE THE FOLLOWING IMMEDIATE ACTIONS: Contact family to inform them of the newborn screening result and ascertain clinical status
(poor feeding, vomiting, lethargy). Consult with pediatric metabolic specialist. Evaluate the newborn (poor feeding, lethargy, hypotonia, hepatomegaly). If signs are present
or infant is ill, initiate emergency treatment with IV glucose. Transport to hospital for further treatment in consultation with metabolic specialist. If infant is normal initiate timely confirmatory/diagnostic testing, as recommended by specialist.
Educate family about need for infant to avoid fasting. Even if mildly ill, immediate treatment with IV glucose is needed.
Report findings to newborn screening program. Diagnostic Evaluation: Plasma acylcarnitine analysis will show elevated octanoylcarnitine (C8). Urine acylglycine will show elevated hexanoylglycine. Diagnosis is confirmed by mutation analysis of the MCAD gene. Please check ALL of the following that apply: [ ] Family contacted [ ] Newborn clinical status assessed
[ ] Problems (poor feeding, vomiting, lethargy, hypotonia, hepatomegaly) [ ] Treated with IV glucose [ ] Infant stable
[ ] Family provided attached educational materials Diagnostic Evaluation [ ] Plasma acylcarnitine sent [ ] Referral made to metabolic center [ ] Family could not be contacted [ ] This is not my patient
MEDICAL EMERGENCY - TAKE THE FOLLOWING IMMEDIATE ACTIONS: Contact family to inform them of the newborn screening result and ascertain clinical status
(poor feeding, vomiting, lethargy). Consult with pediatric metabolic specialist. Evaluate the newborn (poor feeding, lethargy, hypotonia, hepatomegaly). If signs are present
or infant is ill, initiate emergency treatment with IV glucose. Transport to hospital for further treatment in consultation with metabolic specialist. If infant is normal initiate timely confirmatory/diagnostic testing, as recommended by specialist.
Educate family about need for infant to avoid fasting. Even if mildly ill, immediate treatment with IV glucose is needed.
Report findings to newborn screening program.
Please check ALL of the following that apply: [ ] Family contacted [ ] Newborn clinical status assessed
[ ] Problems (poor feeding, vomiting, lethargy, hypotonia, hepatomegaly) [ ] Treated with IV glucose [ ] Infant stable
[ ] Family provided attached educational materials Diagnostic Evaluation [ ] Plasma acylcarnitine sent [ ] Referral made to metabolic center [ ] Family could not be contacted [ ] This is not my patient
X
XX
XX
September 27, 2007
Jennifer D. Patient DOB: 14 May 2007 Newborn Screening Alert: Elevated C8 with Lesser Elevations of C6 and C10 Acylcarnitine Suggestive of Medium-chain Acyl-CoA Dehydrogenase (MCAD) Deficiency Condition Description: MCAD deficiency is a fatty acid oxidation (FAO) disorder. FAO occurs during prolonged fasting and/or periods of increased energy demands (fever, stress) when energy production relies increasingly on fat metabolism. In an FAO disorder, fatty acids and potentially toxic derivatives accumulate because of a deficiency in one of the mitochondrial FAO enzymes. MEDICAL EMERGENCY - TAKE THE FOLLOWING IMMEDIATE ACTIONS: Contact family to inform them of the newborn screening result and ascertain clinical status
(poor feeding, vomiting, lethargy). Consult with pediatric metabolic specialist. Evaluate the newborn (poor feeding, lethargy, hypotonia, hepatomegaly). If signs are present
or infant is ill, initiate emergency treatment with IV glucose. Transport to hospital for further treatment in consultation with metabolic specialist. If infant is normal initiate timely confirmatory/diagnostic testing, as recommended by specialist.
Educate family about need for infant to avoid fasting. Even if mildly ill, immediate treatment with IV glucose is needed.
Report findings to newborn screening program. Diagnostic Evaluation: Plasma acylcarnitine analysis will show elevated octanoylcarnitine (C8). Urine acylglycine will show elevated hexanoylglycine. Diagnosis is confirmed by mutation analysis of the MCAD gene. Please check ALL of the following that apply: [ ] Family contacted [ ] Newborn clinical status assessed
[ ] Problems (poor feeding, vomiting, lethargy, hypotonia, hepatomegaly) [ ] Treated with IV glucose [ ] Infant stable
[ ] Family provided attached educational materials Diagnostic Evaluation [ ] Plasma acylcarnitine sent [ ] Referral made to metabolic center [ ] Family could not be contacted [ ] This is not my patient
RULES:IF lurelicubwliucTHEN isjfafkjdf;lksdfIF lurelicubwliucTHEN isjfafkjdf;lksdfIF lurelicubwliucTHEN isjfafkjdf;lksdfIF lurelicubwliucTHEN isjfafkjdf;lksdfIF lurelicubwliucTHEN isjfafkjdf;lksdfIF lurelicubwliucTHEN isjfafkjdf;lksdf
Database
Knowledge Base
Generating the ATD
September 27, 2007
Avoiding Missed Opportunities
• Capture HL7 message for neonates
INPCINPC
• Check against newborn screening reports
• Alert physician if missing or positive
September 27, 2007
MSH|^~\&|RLY_NB|RILEY|NEWBORN|REGEN|20051202070251||ORU^R01|||2.3PID|||72360601||Doe^John||20050908155100|M|Jones|White||||||||||||Non HispanicNK1||Doe^Jane|Mother|123 MAIN STREET^^GREENWOOD^IN^46143^^^^JOHNSON|3175350809|||||||||||19791116PV1|||||||^SMITH^LYNETTE
Probabilistic Matching withHL7 Messages
Infant LName = DoeInfant FName = JohnInfant DOB = 9/8/2005Infant Sex = MaleInfant Race = WhiteInfant Ethnicity = Non HispanicMother LName = DoeMother FName = JaneMother Street = 123 Main StreetMother City = GreenwoodMother State = INMother Zip = 46143Mother County = JohnsonMother Phone = 317-535-0809
Infant LName = DoeInfant FName = BabyInfant DOB = 9/8/2005Infant Sex = MaleInfant Race = WhiteInfant Ethnicity = Mother LName = DoeMother FName = JaneMother Street = 123 Main StreetMother City = GreenwoodMother State = INMother Zip = 46143Mother County =Mother Phone = 317-555-1828
September 27, 2007
318 un-linked HL7 records
Riley (100,785 unique records)
INPC (2,561 total unique records)
2,243 linked HL7 records
97,960 un-linked Riley records2,825 linked Riley records 1,107 un-linked Riley records with
Indianapolis address
September 27, 2007
Explaining Unmatched Cases
• Manual Review of 300 “children” whose HL7 messages did not match a newborn screen– 200 “junk” messages
• E.g., did not contain PID and NK1 segments
– 70 messages could be manually linked to an infant with a newborn screen
• Matching algorithm needs refining
– 30 appear not to have had a newborn screen
September 27, 2007
Long Term Follow-up Data Collection
Dr. Emmet Cal Holmes Kids Klinic Primary Care Ln Lebanon, IN RE: Jennifer Johnson, DOB: 9/30/06 Dear Dr. Holmes: We are following up children with conditions identified by newborn screening. Jennifer Johnson was identified as having VLCAD. Our records show that she is in your care. We need your help in following her growth, development and general health. Please answer the following few questions at your earliest convenience and fax to 1-800-555-2800. Is Jennifer still in your care? [_]YES [_] NO If NO, please provide any contact information you may have Street address [_|_|_|_|_|_|_|_|_|_|_|_|_|_|_|_|_|_] [_|_|_|_|_|_|_|_|_|_|_|_|_|_|_|_|_|_] City, state, zip [_|_|_|_|_|_|_|_|_|_|_|_|_|_|_|_|_|_], [_|_] [_|_|_|_|_|] Phone ([_|_|_]) [_|_|_]-[_|_|_|_] Data last seen (mm/dd/yy): [_|_]/[_|_]/[_|_] Development: Normal Concerning Gross motor [_] [_] Fine motor [_] [_] Personal-Social [_] [_] Language [_] [_] Growth: Height [_|_|_].[_] [_] inches [_] centimeters Weight [_|_|_].[_] [_] pounds [_] kilograms Has Jennifer been hospitalized in the last year? [_]YES [_] NO If yes, how many times? [_|_|_]
Is Jennifer still in your care? [_]YES [_] NO If NO, please provide any contact information you may have Street address [_|_|_|_|_|_|_|_|_|_|_|_|_|_|_|_|_|_] [_|_|_|_|_|_|_|_|_|_|_|_|_|_|_|_|_|_] City, state, zip [_|_|_|_|_|_|_|_|_|_|_|_|_|_|_|_|_|_], [_|_] [_|_|_|_|_|] Phone ([_|_|_]) [_|_|_]-[_|_|_|_] Data last seen (mm/dd/yy): [_|_]/[_|_]/[_|_] Development: Normal Concerning Gross motor [_] [_] Fine motor [_] [_] Personal-Social [_] [_] Language [_] [_] Growth: Height [_|_|_].[_] [_] inches [_] centimeters Weight [_|_|_].[_] [_] pounds [_] kilograms Has Jennifer been hospitalized in the last year? [_]YES [_] NO If yes, how many times? [_|_|_]
September 27, 2007
Electronic Lab Reporting
• Reportable disease HL7 messages are sent to ISDH and Local Public Health daily.
September 27, 2007
Reportable Condition Processor
InboundInboundHL7HL7
PotentiallyPotentiallyReportableReportable
ReportableReportableConditionCondition
ReportableReportableConditionsConditionsDatabasesDatabases
ReportableReportableConditionsConditionsDatabasesDatabases
Abnormal flag,Organism name, Value above threshold
Record Countas denominator
E-mailE-mailSummaSumma
ryryRealtime Daily Batch
PrintPrintReportsReports
To PublicTo PublicHealthHealth
To InfectionTo InfectionControlControl
September 27, 2007
Syndromic Surveillance Basics
Signal: Alarm threshold
Weekly ED Gastrointestinal Syndromes
27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46
Week
Alarm Threshold
Event:
Time
GI Outbreak
September 27, 2007
89.5, -36.788.6, -35.589.1, -36.188.9, -36.488.7, -35.889.2, -36.088.8, -36.289.3, -35.9
89.5, -36.788.6, -35.589.1, -36.188.9, -36.488.7, -35.889.2, -36.088.8, -36.289.3, -35.9
GIRESPRESPCONSTRASHRASHGIRESP
89.5, -36.788.8, -36.2
GIGI
88.6, -35.589.1, -36.189.3, -35.9
RESPRESPRESP
88.9, -36.4CONST88.7, -35.889.2, -36.0
RASHRASH
Geoco
de
Syn
dro
me
Cla
ssify
Seg
regat
e
ED Data
September 27, 2007
September 27, 2007
Current PHESS
Hospitals (n=72)
Goal of 78 hospitals by August 2007
> 6,500 visits per day~ 15 MB data per day
September 27, 2007
Maintenance: Title: MCAD Reminder;; Filename: mcad;; Version: 0.2;; Institution: Indiana University School of Medicine;; Author: Steve Downs;; Specialist: Pediatrics;; Date: 05-22-2007;; Validation: ;; Library: Purpose: Provides a specific reminder, tailored to the patient who identified one or more fatty acid disorders;; Explanation: Based on AAP screening recommendations;; Keywords: fatty, acid, fatty acid disorder;; Citations: Screening for fatty acid disorder AAP;; Links: ;; Knowledge: Type: data_driven;; /* Priority: 232;; Evoke: ;; Urgency: ;; */ Data: fa := read last {FATTY ACID DISORDERS} ; hal := read last {TYPE OF PROTEIN FEED} ; ;; Priority: 232;; Evoke: ;; Logic: If hal = 'HYPERAL(TPN)' then conclude False; If fa = 'C8-C-01-003' then conclude True; ;; Action:write ("The above results are suggestive of Medium Chain ACYL-CoA Dehydrogenase Deficiency. An immediate recollection is necessary to further evaluate this infant"); ;; end:
Arden SyntaxMedical Logic Module
Data: fa := read last {FATTY ACID DISORDERS} ; hal := read last {TYPE OF PROTEIN FEED} ; ;; Priority: 232;; Evoke: ;; Logic: If hal = 'HYPERAL(TPN)' then conclude False; If fa = 'C8-C-01-003' then conclude True; ;; Action:write ("The above results are suggestive of Medium Chain ACYL-CoA Dehydrogenase Deficiency. An immediate recollection is necessary to further evaluate this infant");
September 27, 2007
Probabilistic Scoring ExampleAGREEMENT RATES
• 2 files, 10 Records each
• Form all possible pairs: 10 x 10 = 100 pairs
• Human review of all 100 record pairs shows that 10 are true-links, 90 are non-links.
September 27, 2007
Probabilistic Scoring Example AGREEMENT RATES
• Among the 10 true-links, the last names agreed in 9/10 pairs (e.g. one of the last names was misspelled)
• This represents a 90% AGREEMENT RATE for last name among TRUE LINKS.
• Similarly, among the 90 non-links, last names agreed (by random chance) in 2/90 pairs
• This represents a 2% AGREEMENT RATE for last name among NON-LINKS.
September 27, 2007
Probabilistic Scoring Example AGREEMENT RATES
90%90%
2%2%
= = 4545 Records that agree on last Records that agree on last name are name are 45 45 times more likely times more likely to be a true-link than a non-to be a true-link than a non-linklink Weights for each field are combined to Weights for each field are combined to
form a composite record pair score.form a composite record pair score. Field disagreement contributes a Field disagreement contributes a
negative weight, and reduces the overall negative weight, and reduces the overall record pair score.record pair score.
September 27, 2007
No Change in Workflow
• Since PHESS requires information that is already being collected by the registration system, there is – no change in work flow, (unless chief complaint is not
currently captured)
• The only upfront work involved is setting up connectivity and an HL7 interface. – On average it takes approximately 11 hours of a network
engineer and interface programmer’s time for this project– Record go live time set on 3/6/2006 – under 3 hrs